These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 2956472

  • 1. 6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors.
    Porceddu ML, Giorgi O, De Montis G, Mele S, Cocco L, Ongini E, Biggio G.
    Life Sci; 1987 Aug 10; 41(6):697-706. PubMed ID: 2956472
    [Abstract] [Full Text] [Related]

  • 2. Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase.
    Filloux F, Dawson TM, Wamsley JK.
    Brain Res Bull; 1988 Apr 10; 20(4):447-59. PubMed ID: 3135077
    [Abstract] [Full Text] [Related]

  • 3. 3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine.
    Porceddu ML, Giorgi O, Ongini E, Mele S, Biggio G.
    Life Sci; 1986 Jul 28; 39(4):321-8. PubMed ID: 3526066
    [Abstract] [Full Text] [Related]

  • 4. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
    Hervé D, Trovero F, Blanc G, Glowinski J, Tassin JP.
    Neuroscience; 1992 Jul 28; 46(3):687-700. PubMed ID: 1532052
    [Abstract] [Full Text] [Related]

  • 5. Striatal D1 dopamine receptor distribution following chemical lesion of the nigrostriatal pathway.
    Ariano MA.
    Brain Res; 1988 Mar 08; 443(1-2):204-14. PubMed ID: 2965958
    [Abstract] [Full Text] [Related]

  • 6. Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat.
    Savasta M, Dubois A, Benavides J, Scatton B.
    Neurosci Lett; 1986 Dec 23; 72(3):265-71. PubMed ID: 2950341
    [Abstract] [Full Text] [Related]

  • 7. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--II. Differential localization of dopamine and cholecystokinin receptors.
    Beresford IJ, Davenport AP, Sirinathsinghji DJ, Hall MD, Hill RG, Hughes J.
    Neuroscience; 1988 Oct 23; 27(1):129-43. PubMed ID: 3264392
    [Abstract] [Full Text] [Related]

  • 8. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):83-91. PubMed ID: 1321631
    [Abstract] [Full Text] [Related]

  • 9. Postnatal development of striatal dopamine function. II. Effects of neonatal 6-hydroxydopamine treatments on D1 and D2 receptors, adenylate cyclase activity and presynaptic dopamine function.
    Broaddus WC, Bennett JP.
    Brain Res Dev Brain Res; 1990 Mar 01; 52(1-2):273-7. PubMed ID: 2110042
    [Abstract] [Full Text] [Related]

  • 10. Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.
    Andersen PH, Braestrup C.
    J Neurochem; 1986 Dec 01; 47(6):1822-31. PubMed ID: 2945903
    [Abstract] [Full Text] [Related]

  • 11. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
    Quik M, Emson PC, Joyce E.
    Brain Res; 1979 May 11; 167(2):355-65. PubMed ID: 36204
    [Abstract] [Full Text] [Related]

  • 12. Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra.
    Dawson TM, Dawson VL, Gage FH, Fisher LJ, Hunt MA, Wamsley JK.
    Exp Neurol; 1991 Mar 11; 111(3):282-92. PubMed ID: 1825638
    [Abstract] [Full Text] [Related]

  • 13. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):73-82. PubMed ID: 1321630
    [Abstract] [Full Text] [Related]

  • 14. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y, Pélaprat D, Montagne MN, Scherman D, Rostène W.
    Brain Res; 1990 Mar 05; 510(2):203-10. PubMed ID: 1970504
    [Abstract] [Full Text] [Related]

  • 15. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors.
    Trovero F, Hervé D, Blanc G, Glowinski J, Tassin JP.
    J Neurochem; 1992 Jul 05; 59(1):331-7. PubMed ID: 1351927
    [Abstract] [Full Text] [Related]

  • 16. Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum.
    Giorgi O, De Montis G, Porceddu ML, Mele S, Calderini G, Toffano G, Biggio G.
    Brain Res; 1987 Oct 05; 432(2):283-90. PubMed ID: 2960426
    [Abstract] [Full Text] [Related]

  • 17. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH, Dvorkin B.
    Brain Res; 1986 Dec 05; 387(3):261-70. PubMed ID: 2950967
    [Abstract] [Full Text] [Related]

  • 18. Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity.
    Luthman J, Lindqvist E, Young D, Cowburn R.
    Exp Brain Res; 1990 Dec 05; 83(1):85-95. PubMed ID: 1981564
    [Abstract] [Full Text] [Related]

  • 19. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
    Starr M.
    J Neurochem; 1987 Oct 05; 49(4):1042-9. PubMed ID: 2957468
    [Abstract] [Full Text] [Related]

  • 20. Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
    Kelly E, Jenner P, Marsden CD.
    J Neurochem; 1985 Jul 05; 45(1):137-44. PubMed ID: 3923157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.